LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY

被引：0
|
作者：
Blank, N. [1 ]
Schuetz, C. [2 ]
Henes, J. [3 ,4 ]
Kallinich, T. [5 ]
Oommen, P. [6 ]
Borte, M. [7 ]
Hufnagel, M. [8 ]
Janda, A. [9 ]
Weber-Arden, J. [10 ]
Kuemmerle-Deschner, J. B. [11 ]
机构：
[1] Univ Hosp Heidelberg, Rheumatol, Heidelberg, Germany
[2] Tech Univ Dresden, Pediat, Med Fak Carl Gustav Carus, Dresden, Germany
[3] Univ Hosp Tuebingen, Inflammatory Dis, Ctr Interdisciplinary Rheumatol Immunol & Auto In, Tubingen, Germany
[4] Univ Hosp Tuebingen, Dept Internal Med 2, Tubingen, Germany
[5] Charite Univ Med Berlin, Div Pulmonol Immunol & Crit Care Med, Dept Pediat, Berlin, Germany
[6] Heinrich Heine Univ Dusseldorf, Div Pediat Rheumatol, Clin Pediat Hematol Oncol & Clin Immunol, Dusseldorf, Germany
[7] Hosp St Georg gGmbH Leipzig, ImmunoDeficiency Ctr Leipzig IDCL, Leipzig, Germany
[8] Univ Freiburg, Univ Hosp Med Ctr, Med Fac, Dept Pediat & Adolescent Med,Div Pediat Infect Di, Freiburg, Germany
[9] Univ Hosp Ulm, Dept Pediat, Ulm, Germany
[10] Novartis Pharma GmbH, IHD, Nurnberg, Germany
[11] Univ Hosp Tuebingen, Div Pediat Rheumatol, Dept Pediat, Tubingen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.4973
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0221
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [1] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Blank, N.
    Henes, J.
    Kallinich, T.
    Oommen, P.
    Schuetz, C.
    Borte, M.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 972 - 973
  • [2] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Blank, N.
    Schuetz, C.
    Hufnagel, M.
    Horneff, G.
    Borte, M.
    Kallinich, T.
    Oommen, P.
    Janda, A.
    Henes, J.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1162 - 1163
  • [3] Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic Syndrome (TRAPS) - Long-term Efficacy and Safety Data from a RELIANCE Registry Interim Analysis
    Blank, Norbert
    Schuetz, Catharina
    Henes, Joerg
    Kallinich, Tilmann
    Oommen, Prasad T.
    Borte, Michael
    Hufnagel, Markus
    Janda, Ales
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin B.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1614 - 1616
  • [4] Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
    Francesco La Torre
    Maurizio Muratore
    Antonio Vitale
    Fulvio Moramarco
    Laura Quarta
    Luca Cantarini
    Rheumatology International, 2015, 35 : 1943 - 1947
  • [5] Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
    La Torre, Francesco
    Muratore, Maurizio
    Vitale, Antonio
    Moramarco, Fulvio
    Quarta, Laura
    Cantarini, Luca
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (11) : 1943 - 1947
  • [6] Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial
    Gattorno, Marco
    Obici, Laura
    Penades, Inmaculada Calvo
    Kallinich, Tilmann
    Benseler, Susanne
    Dekker, Elise
    Levy, Jeremy
    De Benedetti, Fabrizio
    Lachmann, Helen
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (02) : 304 - 312
  • [7] Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin
    Henes, Jorg
    Kortus-Goetze, Birgit
    Kallinich, Tilmann
    Oommen, Prasad T.
    Rech, Juergen
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Janda, Ales
    Schuetz, Catharina
    Dressler, Frank
    Borte, Michael
    Hufnagel, Markus
    Braner, Axel
    Meier, Florian
    Fiene, Michael
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 379 - 380
  • [8] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Oommen, P.
    Kallinich, T.
    Rech, J.
    Blank, N.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1978 - 1978
  • [9] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Oommen, P.
    Kallinich, T.
    Rech, J.
    Blank, N.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1027 - 1028
  • [10] LONG-TERM SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY DISEASES - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Henes, J.
    Kortus-Goetze, B.
    Kallinich, T.
    Oommen, P.
    Rech, J.
    Krickau, T.
    Weller-Heinemann, F.
    Horneff, G.
    Janda, A.
    Foeldvari, I.
    Schuetz, C.
    Dressler, F.
    Borte, M.
    Hufnagel, M.
    Meier, F.
    Fiene, M.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1026 - 1027
12345